SCI Pharmtech Inc
TWSE:4119
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
86.4
100
|
| Price Target |
|
We'll email you a reminder when the closing price reaches TWD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
SCI Pharmtech Inc
Other Current Liabilities
SCI Pharmtech Inc
Other Current Liabilities Peer Comparison
4746
1789
1795
1720
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Other Current Liabilities
NT$468.3m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
5%
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Other Current Liabilities
NT$1.7B
|
CAGR 3-Years
34%
|
CAGR 5-Years
5%
|
CAGR 10-Years
3%
|
|
|
Formosa Laboratories Inc
TWSE:4746
|
Other Current Liabilities
NT$679.4m
|
CAGR 3-Years
20%
|
CAGR 5-Years
11%
|
CAGR 10-Years
19%
|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Other Current Liabilities
NT$672.8m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-7%
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Other Current Liabilities
NT$3.3B
|
CAGR 3-Years
28%
|
CAGR 5-Years
28%
|
CAGR 10-Years
32%
|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Other Current Liabilities
NT$1.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
6%
|
See Also
What is SCI Pharmtech Inc's Other Current Liabilities?
Other Current Liabilities
468.3m
TWD
Based on the financial report for Jun 30, 2024, SCI Pharmtech Inc's Other Current Liabilities amounts to 468.3m TWD.
What is SCI Pharmtech Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
5%
Over the last year, the Other Current Liabilities growth was 35%. The average annual Other Current Liabilities growth rates for SCI Pharmtech Inc have been -11% over the past three years , -6% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet
